{"id":"https://genegraph.clinicalgenome.org/r/b6626103-620c-4a5d-94ee-793ea74c7301v1.1","type":"EvidenceStrengthAssertion","dc:description":["*TBX20* was first reported in relation to autosomal dominant congenital heart disease in 2007 (Kirk et al.,(2007) PMID:17668378). Eleven variants (missense, nonsense) that have been reported in eleven probands in seven publications (PMID:17668378, 19762328,18834961, 25183037,27510170, 28553164, 37481008) are included in this curation. This gene-disease relationship is also supported by animal models and protein interaction experimental evidence with GATA4 and NKX2.5 which are two genes that have been definitively associated with isolated congenital heart disease (PMID: 14550786, 15843414,19494035, 22328084). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date May 7th 2024 (SOP Version 10).","*TBX20* was first reported in relation to autosomal dominant congenital heart disease in 2007 (Kirk et al.,(2007) PMID:17668378). Eleven variants (missense, nonsense) that have been reported in eleven probands in seven publications (PMID:17668378, 19762328,18834961, 25183037,27510170, 28553164, 37481008) are included in this curation. This gene-disease relationship is also supported by animal models and protein interaction experimental evidence with* GATA4* and *NKX2.5* which are two genes that have been definitively associated with isolated congenital heart disease (PMID: 14550786, 15843414,19494035, 22328084). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date May 7th 2024 (SOP Version 10)."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b6626103-620c-4a5d-94ee-793ea74c7301","GCISnapshot":"https://genegraph.clinicalgenome.org/r/67706e90-ac03-4b96-94e2-4a561ced4a41","calculatedEvidenceStrength":"Moderate","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/67706e90-ac03-4b96-94e2-4a561ced4a41_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2025-10-10T18:22:14.535Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/67706e90-ac03-4b96-94e2-4a561ced4a41_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":["2024-05-07T16:00:00.000Z","2024-05-07T05:00:00.000Z"],"role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67706e90-ac03-4b96-94e2-4a561ced4a41_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9370332-b11d-4728-8f97-81ec22849d45","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9370332-b11d-4728-8f97-81ec22849d45_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28553164","allele":{"id":"https://genegraph.clinicalgenome.org/r/837b7feb-07c7-4891-8264-25a6036d1752","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.820A>T (p.Lys274Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA367263850"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e9370332-b11d-4728-8f97-81ec22849d45_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analyses by using a dual-luciferase reporter assay system showed that the mutant TBX20 lost the ability to transactivate the target gene ANF. Furthermore, the mutation reduced the synergistic activation between TBX20 and NKX2.5 as well as GATA4, two other transcriptional factors previously associated with various CHD, encompassing TO","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e5f04d23-1bc8-46a9-8591-88a787d1c90b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5f04d23-1bc8-46a9-8591-88a787d1c90b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17668378","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e459948-8111-433d-8b99-5c95fbde42d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.456C>G (p.Ile152Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116972"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e5f04d23-1bc8-46a9-8591-88a787d1c90b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Biophysical studies of the purified bacterially expressed T-box domain confirmed direct effects of this mutation on tertiary protein structure, thermal stability, and DNA binding","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0b20eded-f46d-469b-83b5-e84bc9fefc42","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b20eded-f46d-469b-83b5-e84bc9fefc42_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18834961","allele":{"id":"https://genegraph.clinicalgenome.org/r/4672f746-a4f9-4cb6-aba4-a12c01163cfd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.361A>T (p.Ile121Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA367264917"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fdf7800c-49a1-4ad9-94cc-a8cb29f63feb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdf7800c-49a1-4ad9-94cc-a8cb29f63feb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27510170","allele":{"id":"https://genegraph.clinicalgenome.org/r/adb1f01e-1efd-4b9b-ba99-45fdde58b436","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.427G>T (p.Glu143Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA367264767"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/fdf7800c-49a1-4ad9-94cc-a8cb29f63feb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional assays using a dual‑luciferase reporter assay system revealed that the truncated TBX20 protein had no transcriptional activity in contrast to its wild‑type counterpart. Furthermore, the mutation abolished the synergistic activation between TBX20 and NK2 homeobox 5, or between TBX20 and GATA binding protein 4","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/915a0bba-435b-4d0e-af3d-1a06e2488489","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/915a0bba-435b-4d0e-af3d-1a06e2488489_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18834961","allele":{"id":"https://genegraph.clinicalgenome.org/r/58fc493f-b91e-407c-8756-e50720bd13f9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.666C>T (p.Asn222=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA454498359"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d2ce33b7-21b9-4e25-b790-89becb43cbdb","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2ce33b7-21b9-4e25-b790-89becb43cbdb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18834961","allele":{"id":"https://genegraph.clinicalgenome.org/r/c19428d3-a168-420a-a1fa-1cd34128f691","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.785C>T (p.Thr262Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4217432"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2130fde0-a5ef-47e2-905e-81a719426b76","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2130fde0-a5ef-47e2-905e-81a719426b76_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19762328","allele":{"id":"https://genegraph.clinicalgenome.org/r/54dfd33f-731b-4378-9294-a7f4c68d2fc2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.363C>G (p.Ile121Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116977"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/2130fde0-a5ef-47e2-905e-81a719426b76_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis revealed that the I121M mutant had significantly enhanced transcriptional activity, which was further increased in the presence of co-transcription factors GATA4 (600576)/GATA5 (611496) and NKX2-5 (600584)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8489f88b-54a8-454b-a32c-1792c4c5a1c6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8489f88b-54a8-454b-a32c-1792c4c5a1c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18834961","allele":{"id":"https://genegraph.clinicalgenome.org/r/4e51dc3c-9f01-42ad-86b6-5dfdde485b0e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.786G>C (p.Thr262=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA454498256"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/67706e90-ac03-4b96-94e2-4a561ced4a41_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c19e45fc-db77-4fba-8cf3-b5ae84416ed0_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27510170","rdfs:label":"Family 1 Zhou ","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/c19e45fc-db77-4fba-8cf3-b5ae84416ed0","type":"Family","rdfs:label":"Family 1 Zhou ","member":{"id":"https://genegraph.clinicalgenome.org/r/ef166e11-2bc1-471b-b1a7-27b2151fb7aa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27510170","rdfs:label":"III-3 (Publication Proband’s Niece) ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/adb1f01e-1efd-4b9b-ba99-45fdde58b436"},"detectionMethod":"Direct sequencing of TBX20 ","firstTestingMethod":"Other","phenotypes":"obo:HP_0001631","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fdf7800c-49a1-4ad9-94cc-a8cb29f63feb_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":10,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ef166e11-2bc1-471b-b1a7-27b2151fb7aa"}},{"id":"https://genegraph.clinicalgenome.org/r/e5b90cb5-d9ab-4120-ad1d-d708898f5f91_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17668378","rdfs:label":"Kirk_Family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e5b90cb5-d9ab-4120-ad1d-d708898f5f91","type":"Family","rdfs:label":"Kirk_Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/672d7e33-8124-4c24-8973-f166c7551a63","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17668378","rdfs:label":"III:1 Kirk Family 1 Proband ","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e459948-8111-433d-8b99-5c95fbde42d3"},"phenotypes":"obo:HP_0001631","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e5f04d23-1bc8-46a9-8591-88a787d1c90b_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001631","obo:HP_0001629","obo:HP_0001655"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/672d7e33-8124-4c24-8973-f166c7551a63"}},{"id":"https://genegraph.clinicalgenome.org/r/5df600a9-a5f5-464a-b864-abd314a7f0ce_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28553164","rdfs:label":"Family A Huang ","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/5df600a9-a5f5-464a-b864-abd314a7f0ce","type":"Family","rdfs:label":"Family A Huang ","member":{"id":"https://genegraph.clinicalgenome.org/r/d94e1f9e-9028-4f9f-93b1-9f07a3509612","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28553164","rdfs:label":"II-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/837b7feb-07c7-4891-8264-25a6036d1752"},"detectionMethod":"Direct sequencing of TBX20 ","firstTestingMethod":"Other","phenotypes":["obo:HP_0001629","obo:HP_0001660"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e9370332-b11d-4728-8f97-81ec22849d45_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001660","obo:HP_0001629","obo:HP_0001636","obo:HP_0001631"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d94e1f9e-9028-4f9f-93b1-9f07a3509612"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/158f22f4-a18e-4a22-b60a-bcaff2dfd8ba_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25183037","rdfs:label":"Liu JJ Family ","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/158f22f4-a18e-4a22-b60a-bcaff2dfd8ba","type":"Family","rdfs:label":"Liu JJ Family ","member":{"id":"https://genegraph.clinicalgenome.org/r/1370e022-c384-4b0d-ae26-9f2dc758cf8f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25183037","rdfs:label":"III-1 Male  Chinese Liu JJ","ageType":"AgeAtReport","ageUnit":"Months","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6126d554-2e05-4a6d-aad9-1445037f38d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.526G>A (p.Asp176Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA367264556"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"secundum ASD measuring 15 mm in dimension","phenotypes":["obo:HP_0005133","obo:HP_0001684","obo:HP_0030718"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a789478f-5fc1-40fc-a519-616e489354c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25183037","allele":{"id":"https://genegraph.clinicalgenome.org/r/6126d554-2e05-4a6d-aad9-1445037f38d1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0001684","proband":{"id":"https://genegraph.clinicalgenome.org/r/1370e022-c384-4b0d-ae26-9f2dc758cf8f"}},{"id":"https://genegraph.clinicalgenome.org/r/2c3e8d29-3685-46c7-9ad7-cd404ca18c3c_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations with confirmed mutation. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17668378","rdfs:label":"Kirk Family 2 TBX20 ","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/2c3e8d29-3685-46c7-9ad7-cd404ca18c3c","type":"Family","rdfs:label":"Kirk Family 2 TBX20 ","member":{"id":"https://genegraph.clinicalgenome.org/r/81705f24-044d-4066-b926-2a4d502c9af4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17668378","rdfs:label":"Kirk Family 2 Proband TBX20","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/84624585-bf79-4ea6-9767-d8b06b37d57e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.583C>T (p.Gln195Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116974"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001680","obo:HP_0001631"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ca5f9f67-ef13-41fb-99f9-804cc0375e44_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17668378","allele":{"id":"https://genegraph.clinicalgenome.org/r/84624585-bf79-4ea6-9767-d8b06b37d57e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"septal defect (unspecified, mitral valve disease ","phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0001638","obo:HP_0001680","obo:HP_0001631","obo:HP_0033352"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/81705f24-044d-4066-b926-2a4d502c9af4"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6f1562da-7521-4ccf-bba0-d0ac14b42b63","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f1562da-7521-4ccf-bba0-d0ac14b42b63_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37481008","allele":{"id":"https://genegraph.clinicalgenome.org/r/c1b1f4ee-015c-45ae-b538-426300aa4e1e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001077653.2(TBX20):c.766T>C (p.Phe256Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA156927487"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ca5f9f67-ef13-41fb-99f9-804cc0375e44","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca5f9f67-ef13-41fb-99f9-804cc0375e44_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ca5f9f67-ef13-41fb-99f9-804cc0375e44_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis of TBX20 mutations showed reduced or no activity from the mutant ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a789478f-5fc1-40fc-a519-616e489354c0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a789478f-5fc1-40fc-a519-616e489354c0_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.6},{"id":"https://genegraph.clinicalgenome.org/r/67706e90-ac03-4b96-94e2-4a561ced4a41_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67706e90-ac03-4b96-94e2-4a561ced4a41_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b241e5ff-96e9-4f44-8fb7-0c8cff3020d6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b31a524-c88a-4ba8-8c19-a08e694524fd","type":"Finding","dc:description":"Tbx20 was expressed in myocardium and endocardium, including high levels in endocardial cushions ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14550786","rdfs:label":"Tbx20 Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b24cd159-3911-4328-a1bf-fec52527a1b4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f5c4cd7-8fdd-4db5-8ee2-d3ef5efd3f77","type":"Finding","dc:description":"bx20 physically interacted with cardiac transcription factors Nkx2-5, GATA4, and GATA5, collaborating to synergistically activate cardiac gene expression.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14550786","rdfs:label":"Tbx20 interaction with Nkx2-5, GATA4, and GATA5","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/67706e90-ac03-4b96-94e2-4a561ced4a41_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bef43e8a-bf01-47b3-91eb-32ecad57d81a","type":"EvidenceLine","dc:description":"Downgraded due to not directly showing CHD relation","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/69786d9d-bb13-431d-8c0b-64697f9e8cf2","type":"Finding","dc:description":"Rescue by nmr2 but not by tinman of pnr heterozygotes was also observed in the development of cardiac arrhythmias (Fig. 5). The normalizing effect of nmr overexpression in pnr/+ is also illustrated by the shortening of median length of the heart period, due to a decreased diastolic interval (Fig. 5A–E), and a reversal of the elevated arrhythmias. In sum, nmr overexpression in the mesoderm reversed the slow and irregular heart beat due to reduced pnr function","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19494035","rdfs:label":"Partial loss of GATA factor Pannier impairs adult heart ","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0f6ed62f-1132-46c2-9ea2-70440351d2fd","type":"EvidenceLine","dc:description":"Downgraded from 2 points since this doesn’t show any specific CHD phenotypic evidence","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd48517c-aeb1-47a3-847f-0fb6c619a0d4","type":"Finding","dc:description":"Tbx20 -/- embryos showed grossly abnormal cardiac development and arrested yolk sac vascular remodeling. Ectopic activation of Tbx2 (600747) occurred across the whole heart myogenic field in Tbx20 -/- embryos, likely due to loss of Tbx20 repressive function ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15843414","rdfs:label":"Murine T-box transcription factor Tbx20 ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8ca2c039-156b-4ee6-bd5a-be212debc06f","type":"EvidenceLine","dc:description":"Does not recapitulate the phenotype ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/082f763e-d6c6-4544-8ab1-39a61d2ae2ac","type":"Finding","dc:description":"Conditional ablation of Tbx20 in adult mouse cardiomyocytes results in functional abnormalities within 5 days and rapid progression to heart failure within 15 days. They coupled chromatin immunoprecipitation with transcriptome analyses and identified over 4,000 genes that were differentially expressed between wildtype and Tbx20 -/- adult hearts. About 20% of these genes appeared to be direct Tbx20 targets based on the proximity of putative Tbx20-binding sites. Of the putative direct targets, genes involved preferentially in cardiovascular biology and energy metabolism were downregulated in adult Tbx20 -/- hearts, and genes involved in noncardiac tissues, immune response, and cell cycle and proliferation were upregulated in Tbx20 -/- hearts.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22328084","rdfs:label":"Conditional ablation of Tbx20 in adult mouse cardiomyocytes ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Moderate","sequence":11979,"specifiedBy":"GeneValidityCriteria10","strengthScore":10.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/hp1z7D3GdFw","type":"GeneValidityProposition","disease":"obo:MONDO_0005453","gene":"hgnc:11598","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_67706e90-ac03-4b96-94e2-4a561ced4a41-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}